{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:33:25Z","timestamp":1791599605040,"version":"4.3.4"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,3,16]],"date-time":"2015-03-16T00:00:00Z","timestamp":1426464000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1038\/nm.3822","type":"journal-article","created":{"date-parts":[[2015,3,16]],"date-time":"2015-03-16T15:01:31Z","timestamp":1426518091000},"page":"363-372","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":157,"title":["Characterization of pancreatic NMDA receptors as possible drug targets for diabetes treatment"],"prefix":"10.1038","volume":"21","author":[{"given":"Jan","family":"Marquard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke","family":"Otter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alena","family":"Welters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alin","family":"Stirban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelie","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7234-1435","authenticated-orcid":false,"given":"Jan","family":"Eglinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diran","family":"Herebian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf","family":"Kletke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0161a Skelin","family":"Klemen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andra\u017e","family":"Sto\u017eer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Wnendt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Piemonti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"K\u00f6hler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5959-5729","authenticated-orcid":false,"given":"Jorge","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Thorens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freimut","family":"Schliess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjan Slak","family":"Rupnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Heise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per-Olof","family":"Berggren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaj","family":"Kl\u00f6cker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Meissner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ertan","family":"Mayatepek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Eberhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Kragl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eckhard","family":"Lammert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,3,16]]},"reference":[{"key":"BFnm3822_CR1","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1056\/NEJMra1110560","volume":"367","author":"KS Polonsky","year":"2012","unstructured":"Polonsky, K.S. The past 200 years in diabetes. N. Engl. J. Med. 367, 1332\u20131340 (2012).","journal-title":"N. Engl. J. Med."},{"key":"BFnm3822_CR2","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/nature05482","volume":"444","author":"SE Kahn","year":"2006","unstructured":"Kahn, S.E., Hull, R.L. & Utzschneider, K.M. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444, 840\u2013846 (2006).","journal-title":"Nature"},{"key":"BFnm3822_CR3","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1172\/JCI10761","volume":"106","author":"MK Cavaghan","year":"2000","unstructured":"Cavaghan, M.K., Ehrmann, D.A. & Polonsky, K.S. Interactions between insulin resistance and insulin secretion in the development of glucose intolerance. J. Clin. Invest. 106, 329\u2013333 (2000).","journal-title":"J. Clin. Invest."},{"key":"BFnm3822_CR4","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cmet.2010.04.009","volume":"11","author":"E Ferrannini","year":"2010","unstructured":"Ferrannini, E. The stunned beta cell: a brief history. Cell Metab. 11, 349\u2013352 (2010).","journal-title":"Cell Metab."},{"key":"BFnm3822_CR5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1146\/annurev-physiol-030212-183754","volume":"75","author":"P Rorsman","year":"2013","unstructured":"Rorsman, P. & Braun, M. Regulation of insulin secretion in human pancreatic islets. Annu. Rev. Physiol. 75, 155\u2013179 (2013).","journal-title":"Annu. Rev. Physiol."},{"key":"BFnm3822_CR6","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.cell.2012.07.029","volume":"150","author":"C Talchai","year":"2012","unstructured":"Talchai, C., Xuan, S., Lin, H.V., Sussel, L. & Accili, D. Pancreatic beta cell dedifferentiation as a mechanism of diabetic beta cell failure. Cell 150, 1223\u20131234 (2012).","journal-title":"Cell"},{"key":"BFnm3822_CR7","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0140-6736(11)60207-9","volume":"378","author":"AA Tahrani","year":"2011","unstructured":"Tahrani, A.A., Bailey, C.J., Del Prato, S. & Barnett, A.H. Management of type 2 diabetes: new and future developments in treatment. Lancet 378, 182\u2013197 (2011).","journal-title":"Lancet"},{"key":"BFnm3822_CR8","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/j.amjmed.2009.12.008","volume":"123","author":"RA DeFronzo","year":"2010","unstructured":"DeFronzo, R.A. Overview of newer agents: where treatment is going. Am. J. Med. 123, S38\u2013S48 (2010).","journal-title":"Am. J. Med."},{"key":"BFnm3822_CR9","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1464-5491.2007.02341.x","volume":"25","author":"SA Amiel","year":"2008","unstructured":"Amiel, S.A., Dixon, T., Mann, R. & Jameson, K. Hypoglycaemia in type 2 diabetes. Diabet. Med. 25, 245\u2013254 (2008).","journal-title":"Diabet. Med."},{"key":"BFnm3822_CR10","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1056\/NEJMra1215228","volume":"369","author":"PE Cryer","year":"2013","unstructured":"Cryer, P.E. Mechanisms of hypoglycemia-associated autonomic failure in diabetes. N. Engl. J. Med. 369, 362\u2013372 (2013).","journal-title":"N. Engl. J. Med."},{"key":"BFnm3822_CR11","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S0140-6736(13)62154-6","volume":"383","author":"SE Kahn","year":"2014","unstructured":"Kahn, S.E., Cooper, M.E. & Del Prato, S. Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future. Lancet 383, 1068\u20131083 (2014).","journal-title":"Lancet"},{"key":"BFnm3822_CR12","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.2337\/dc14-0893","volume":"37","author":"R Retnakaran","year":"2014","unstructured":"Retnakaran, R., Kramer, C.K., Choi, H., Swaminathan, B. & Zinman, B. Liraglutide and the preservation of pancreatic beta-cell function in early type 2 diabetes: the LIBRA trial. Diabetes Care 37, 3270\u20133278 (2014).","journal-title":"Diabetes Care"},{"key":"BFnm3822_CR13","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1007\/s00125-013-2877-1","volume":"56","author":"R Jain","year":"2013","unstructured":"Jain, R. et al. Pharmacological inhibition of Eph receptors enhances glucose-stimulated insulin secretion from mouse and human pancreatic islets. Diabetologia 56, 1350\u20131355 (2013).","journal-title":"Diabetologia"},{"key":"BFnm3822_CR14","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.neuroscience.2007.09.079","volume":"150","author":"RE Burris","year":"2007","unstructured":"Burris, R.E. & Hebrok, M. Pancreatic innervation in mouse development and beta-cell regeneration. Neuroscience 150, 592\u2013602 (2007).","journal-title":"Neuroscience"},{"key":"BFnm3822_CR15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ecl.2012.11.001","volume":"42","author":"R Rodriguez-Diaz","year":"2013","unstructured":"Rodriguez-Diaz, R. & Caicedo, A. Novel approaches to studying the role of innervation in the biology of pancreatic islets. Endocrinol. Metab. Clin. North Am. 42, 39\u201356 (2013).","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"BFnm3822_CR16","doi-asserted-by":"crossref","first-page":"11692","DOI":"10.1073\/pnas.1102715108","volume":"108","author":"N Soltani","year":"2011","unstructured":"Soltani, N. et al. GABA exerts protective and regenerative effects on islet beta cells and reverses diabetes. Proc. Natl. Acad. Sci. USA 108, 11692\u201311697 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm3822_CR17","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/nprot.2012.040","volume":"7","author":"R Rodriguez-Diaz","year":"2012","unstructured":"Rodriguez-Diaz, R. et al. Real-time detection of acetylcholine release from the human endocrine pancreas. Nat. Protoc. 7, 1015\u20131023 (2012).","journal-title":"Nat. Protoc."},{"key":"BFnm3822_CR18","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/45280","volume":"402","author":"P Maechler","year":"1999","unstructured":"Maechler, P. & Wollheim, C.B. Mitochondrial glutamate acts as a messenger in glucose-induced insulin exocytosis. Nature 402, 685\u2013689 (1999).","journal-title":"Nature"},{"key":"BFnm3822_CR19","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.cmet.2008.03.004","volume":"7","author":"O Cabrera","year":"2008","unstructured":"Cabrera, O. et al. Glutamate is a positive autocrine signal for glucagon release. Cell Metab. 7, 545\u2013554 (2008).","journal-title":"Cell Metab."},{"key":"BFnm3822_CR20","doi-asserted-by":"crossref","first-page":"14007","DOI":"10.1074\/jbc.M110.183517","volume":"286","author":"ES Di Cairano","year":"2011","unstructured":"Di Cairano, E.S. et al. The glial glutamate transporter 1 (GLT1) is expressed by pancreatic beta-cells and prevents glutamate-induced beta-cell death. J. Biol. Chem. 286, 14007\u201314018 (2011).","journal-title":"J. Biol. Chem."},{"key":"BFnm3822_CR21","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.mce.2011.02.019","volume":"338","author":"N Feldmann","year":"2011","unstructured":"Feldmann, N. et al. Reduction of plasma membrane glutamate transport potentiates insulin but not glucagon secretion in pancreatic islet cells. Mol. Cell. Endocrinol. 338, 46\u201357 (2011).","journal-title":"Mol. Cell. Endocrinol."},{"key":"BFnm3822_CR22","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1096\/fasebj.9.8.7768362","volume":"9","author":"N Inagaki","year":"1995","unstructured":"Inagaki, N. et al. Expression and role of ionotropic glutamate receptors in pancreatic islet cells. FASEB 9, 686\u2013691 (1995).","journal-title":"FASEB"},{"key":"BFnm3822_CR23","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2165\/11207260-000000000-00000","volume":"25","author":"KP Garnock-Jones","year":"2011","unstructured":"Garnock-Jones, K.P. Dextromethorphan\/quinidine: in pseudobulbar affect. CNS Drugs 25, 435\u2013445 (2011).","journal-title":"CNS Drugs"},{"key":"BFnm3822_CR24","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0022-3476(98)70365-8","volume":"132","author":"A Hamosh","year":"1998","unstructured":"Hamosh, A., Maher, J.F., Bellus, G.A., Rasmussen, S.A. & Johnston, M.V. Long-term use of high-dose benzoate and dextromethorphan for the treatment of nonketotic hyperglycinemia. J. Pediatr. 132, 709\u2013713 (1998).","journal-title":"J. Pediatr."},{"key":"BFnm3822_CR25","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1212\/WNL.48.5.1212","volume":"48","author":"KA Nelson","year":"1997","unstructured":"Nelson, K.A., Park, K.M., Robinovitz, E., Tsigos, C. & Max, M.B. High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia. Neurology 48, 1212\u20131218 (1997).","journal-title":"Neurology"},{"key":"BFnm3822_CR26","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1124\/jpet.103.060038","volume":"309","author":"RN Pechnick","year":"2004","unstructured":"Pechnick, R.N. & Poland, R.E. Comparison of the effects of dextromethorphan, dextrorphan, and levorphanol on the hypothalamo-pituitary-adrenal axis. J. Pharmacol. Exp. Ther. 309, 515\u2013522 (2004).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BFnm3822_CR27","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.neuropharm.2008.07.046","volume":"55","author":"K Yashiro","year":"2008","unstructured":"Yashiro, K. & Philpot, B.D. Regulation of NMDA receptor subunit expression and its implications for LTD, LTP, and metaplasticity. Neuropharmacology 55, 1081\u20131094 (2008).","journal-title":"Neuropharmacology"},{"key":"BFnm3822_CR28","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nature13548","volume":"511","author":"CH Lee","year":"2014","unstructured":"Lee, C.H. et al. NMDA receptor structures reveal subunit arrangement and pore architecture. Nature 511, 191\u2013197 (2014).","journal-title":"Nature"},{"key":"BFnm3822_CR29","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/S1474-4422(08)70165-0","volume":"7","author":"LV Kalia","year":"2008","unstructured":"Kalia, L.V., Kalia, S.K. & Salter, M.W. NMDA receptors in clinical neurology: excitatory times ahead. Lancet Neurol. 7, 742\u2013755 (2008).","journal-title":"Lancet Neurol."},{"key":"BFnm3822_CR30","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nn1449","volume":"8","author":"TJ Ngo-Anh","year":"2005","unstructured":"Ngo-Anh, T.J. et al. SK channels and NMDA receptors form a Ca2+-mediated feedback loop in dendritic spines. Nat. Neurosci. 8, 642\u2013649 (2005).","journal-title":"Nat. Neurosci."},{"key":"BFnm3822_CR31","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0896-6273(01)00428-7","volume":"31","author":"JS Isaacson","year":"2001","unstructured":"Isaacson, J.S. & Murphy, G.J. Glutamate-mediated extrasynaptic inhibition: direct coupling of NMDA receptors to Ca(2+)-activated K+ channels. Neuron 31, 1027\u20131034 (2001).","journal-title":"Neuron"},{"key":"BFnm3822_CR32","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nrn2911","volume":"11","author":"GE Hardingham","year":"2010","unstructured":"Hardingham, G.E. & Bading, H. Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders. Nat. Rev. Neurosci. 11, 682\u2013696 (2010).","journal-title":"Nat. Rev. Neurosci."},{"key":"BFnm3822_CR33","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.neuropharm.2013.01.012","volume":"74","author":"TE Bartlett","year":"2013","unstructured":"Bartlett, T.E. & Wang, Y.T. The intersections of NMDAR-dependent synaptic plasticity and cell survival. Neuropharmacology 74, 59\u201368 (2013).","journal-title":"Neuropharmacology"},{"key":"BFnm3822_CR34","first-page":"18","volume":"2","author":"A Rodr\u00edguez-Moreno","year":"2010","unstructured":"Rodr\u00edguez-Moreno, A., Banerjee, A. & Paulsen, O. Presynaptic NMDA receptors and spike timing-dependent depression at cortical synapses. Front. Synaptic Neurosci. 2, 18 (2010).","journal-title":"Front. Synaptic Neurosci."},{"key":"BFnm3822_CR35","doi-asserted-by":"crossref","first-page":"16989","DOI":"10.1016\/S0021-9258(17)32507-3","volume":"269","author":"T Gonoi","year":"1994","unstructured":"Gonoi, T. et al. Functional neuronal ionotropic glutamate receptors are expressed in the non-neuronal cell line MIN6. J. Biol. Chem. 269, 16989\u201316992 (1994).","journal-title":"J. Biol. Chem."},{"key":"BFnm3822_CR36","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0014-5793(95)00890-L","volume":"371","author":"E Moln\u00e1r","year":"1995","unstructured":"Moln\u00e1r, E., Varadi, A., McIlhinney, R.A. & Ashcroft, S.J. Identification of functional ionotropic glutamate receptor proteins in pancreatic beta-cells and in islets of Langerhans. FEBS Lett. 371, 253\u2013257 (1995).","journal-title":"FEBS Lett."},{"key":"BFnm3822_CR37","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1476-5381.1987.tb11209.x","volume":"90","author":"MG Garrino","year":"1987","unstructured":"Garrino, M.G. & Henquin, J.C. Adamantane derivatives: a new class of insulin secretagogues. Br. J. Pharmacol. 90, 583\u2013591 (1987).","journal-title":"Br. J. Pharmacol."},{"key":"BFnm3822_CR38","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s001250050042","volume":"43","author":"D Konrad","year":"2000","unstructured":"Konrad, D., Sobetzko, D., Schmitt, B. & Schoenle, E.J. Insulin-dependent diabetes mellitus induced by the antitussive agent dextromethorphan. Diabetologia 43, 261\u2013262 (2000).","journal-title":"Diabetologia"},{"key":"BFnm3822_CR39","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2147\/DMSO.S7606","volume":"2","author":"F Lechin","year":"2009","unstructured":"Lechin, F. et al. Amantadine reduces glucagon and enhances insulin secretion throughout the oral glucose tolerance test: central plus peripheral nervous system mechanisms. Diabetes Metab. Syndr. Obes. 2, 203\u2013213 (2009).","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"BFnm3822_CR40","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1476-5381.1991.tb12472.x","volume":"104","author":"FM Ashcroft","year":"1991","unstructured":"Ashcroft, F.M., Kerr, A.J., Gibson, J.S. & Williams, B.A. Amantadine and sparteine inhibit ATP-regulated K-currents in the insulin-secreting beta-cell line, HIT-T15. Br. J. Pharmacol. 104, 579\u2013584 (1991).","journal-title":"Br. J. Pharmacol."},{"key":"BFnm3822_CR41","doi-asserted-by":"crossref","first-page":"7104","DOI":"10.1073\/pnas.83.18.7104","volume":"83","author":"EHF Wong","year":"1986","unstructured":"Wong, E.H.F. et al. The anticonvulsant Mk-801 is a potent N-methyl-D-aspartate Antagonist. Proc. Natl. Acad. Sci. USA 83, 7104\u20137108 (1986).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm3822_CR42","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.cell.2013.02.051","volume":"153","author":"L Li","year":"2013","unstructured":"Li, L. & Hanahan, D. Hijacking the neuronal NMDAR signaling circuit to promote tumor growth and invasion. Cell 153, 86\u2013100 (2013).","journal-title":"Cell"},{"key":"BFnm3822_CR43","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1126\/science.2660263","volume":"244","author":"JW Olney","year":"1989","unstructured":"Olney, J.W., Labruyere, J. & Price, M.T. Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 244, 1360\u20131362 (1989).","journal-title":"Science"},{"key":"BFnm3822_CR44","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.celrep.2014.09.030","volume":"9","author":"G Gheni","year":"2014","unstructured":"Gheni, G. et al. Glutamate acts as a key signal linking glucose metabolism to incretin\/cAMP action to amplify insulin secretion. Cell Reports 9, 661\u2013673 (2014).","journal-title":"Cell Reports"},{"key":"BFnm3822_CR45","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00424-003-1097-9","volume":"446","author":"S Speier","year":"2003","unstructured":"Speier, S. & Rupnik, M. A novel approach to in situ characterization of pancreatic beta-cells. Pflugers Arch. 446, 553\u2013558 (2003).","journal-title":"Pflugers Arch."},{"key":"BFnm3822_CR46","doi-asserted-by":"crossref","first-page":"10402","DOI":"10.1073\/pnas.95.18.10402","volume":"95","author":"T Miki","year":"1998","unstructured":"Miki, T. et al. Defective insulin secretion and enhanced insulin action in KATP channel-deficient mice. Proc. Natl. Acad. Sci. USA 95, 10402\u201310406 (1998).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm3822_CR47","doi-asserted-by":"crossref","first-page":"47681","DOI":"10.1074\/jbc.M409627200","volume":"279","author":"T Begenisich","year":"2004","unstructured":"Begenisich, T. et al. Physiological roles of the intermediate conductance, Ca2+-activated potassium channel Kcnn4. J. Biol. Chem. 279, 47681\u201347687 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFnm3822_CR48","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.2337\/db08-1324","volume":"58","author":"M D\u00fcfer","year":"2009","unstructured":"D\u00fcfer, M. et al. Enhanced glucose tolerance by SK4 channel inhibition in pancreatic beta-cells. Diabetes 58, 1835\u20131843 (2009).","journal-title":"Diabetes"},{"key":"BFnm3822_CR49","doi-asserted-by":"crossref","first-page":"22265","DOI":"10.1016\/S0021-9258(18)41522-0","volume":"268","author":"P Gilon","year":"1993","unstructured":"Gilon, P., Shepherd, R.M. & Henquin, J.C. Oscillations of secretion driven by oscillations of cytoplasmic Ca2+ as evidences in single pancreatic islets. J. Biol. Chem. 268, 22265\u201322268 (1993).","journal-title":"J. Biol. Chem."},{"key":"BFnm3822_CR50","doi-asserted-by":"crossref","first-page":"8749","DOI":"10.1016\/S0021-9258(17)37032-1","volume":"269","author":"P Bergsten","year":"1994","unstructured":"Bergsten, P., Grapengiesser, E., Gylfe, E., Tengholm, A. & Hellman, B. Synchronous oscillations of cytoplasmic Ca2+ and insulin release in glucose-stimulated pancreatic islets. J. Biol. Chem. 269, 8749\u20138753 (1994).","journal-title":"J. Biol. Chem."},{"key":"BFnm3822_CR51","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/bph.12194","volume":"169","author":"G Bardy","year":"2013","unstructured":"Bardy, G. et al. Quercetin induces insulin secretion by direct activation of L-type calcium channels in pancreatic beta cells. Br. J. Pharmacol. 169, 1102\u20131113 (2013).","journal-title":"Br. J. Pharmacol."},{"key":"BFnm3822_CR52","doi-asserted-by":"crossref","first-page":"12435","DOI":"10.1074\/jbc.M114.562587","volume":"289","author":"PK Dadi","year":"2014","unstructured":"Dadi, P.K. et al. Inhibition of pancreatic beta-cell Ca2+\/calmodulin-dependent protein kinase II reduces glucose-stimulated calcium influx and insulin secretion, impairing glucose tolerance. J. Biol. Chem. 289, 12435\u201312445 (2014).","journal-title":"J. Biol. Chem."},{"key":"BFnm3822_CR53","doi-asserted-by":"crossref","first-page":"e58655","DOI":"10.1371\/journal.pone.0058655","volume":"8","author":"SS Dixit","year":"2013","unstructured":"Dixit, S.S. et al. Effects of CaMKII-mediated phosphorylation of ryanodine receptor type 2 on islet calcium handling, insulin secretion, and glucose tolerance. PLoS ONE 8, e58655 (2013).","journal-title":"PLoS ONE"},{"key":"BFnm3822_CR54","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0165-0173(01)00112-6","volume":"37","author":"T Maurice","year":"2001","unstructured":"Maurice, T., Urani, A., Phan, V.L. & Romieu, P. The interaction between neuroactive steroids and the sigma1 receptor function: behavioral consequences and therapeutic opportunities. Brain Res. Brain Res. Rev. 37, 116\u2013132 (2001).","journal-title":"Brain Res. Brain Res. Rev."},{"key":"BFnm3822_CR55","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/S0140-6736(06)69705-5","volume":"368","author":"DJ Drucker","year":"2006","unstructured":"Drucker, D.J. & Nauck, M.A. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 368, 1696\u20131705 (2006).","journal-title":"Lancet"},{"key":"BFnm3822_CR56","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/BF01222201","volume":"3","author":"DL Coleman","year":"1967","unstructured":"Coleman, D.L. & Hummel, K.P. Studies with the mutation, diabetes, in the mouse. Diabetologia 3, 238\u2013248 (1967).","journal-title":"Diabetologia"},{"key":"BFnm3822_CR57","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrd4275","volume":"13","author":"MY Donath","year":"2014","unstructured":"Donath, M.Y. Targeting inflammation in the treatment of type 2 diabetes: time to start. Nat. Rev. Drug Discov. 13, 465\u2013476 (2014).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFnm3822_CR58","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0079-6107(89)90013-8","volume":"54","author":"FM Ashcroft","year":"1989","unstructured":"Ashcroft, F.M. & Rorsman, P. Electrophysiology of the pancreatic beta-cell. Prog. Biophys. Mol. Biol. 54, 87\u2013143 (1989).","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"BFnm3822_CR59","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1523\/JNEUROSCI.3200-09.2010","volume":"30","author":"KZ Shen","year":"2010","unstructured":"Shen, K.Z. & Johnson, S.W. Ca2+ influx through NMDA-gated channels activates ATP-sensitive K+ currents through a nitric oxide-cGMP pathway in subthalamic neurons. J. Neurosci. 30, 1882\u20131893 (2010).","journal-title":"J. Neurosci."},{"key":"BFnm3822_CR60","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/nn.3185","volume":"15","author":"J Schiemann","year":"2012","unstructured":"Schiemann, J. et al. K-ATP channels in dopamine substantia nigra neurons control bursting and novelty-induced exploration. Nat. Neurosci. 15, 1272\u20131280 (2012).","journal-title":"Nat. Neurosci."},{"key":"BFnm3822_CR61","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1242\/dev.129.10.2447","volume":"129","author":"G Gu","year":"2002","unstructured":"Gu, G., Dubauskaite, J. & Melton, D.A. Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors. Development 129, 2447\u20132457 (2002).","journal-title":"Development"},{"key":"BFnm3822_CR62","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/s00125-014-3468-5","volume":"58","author":"B Thorens","year":"2015","unstructured":"Thorens, B. et al. Ins1Cre knock-in mice for beta cell-specific gene recombination. Diabetologia 58, 558\u2013565 (2015).","journal-title":"Diabetologia"},{"key":"BFnm3822_CR63","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4161\/isl.1.3.9556","volume":"1","author":"P Yesil","year":"2009","unstructured":"Yesil, P. et al. A new collagenase blend increases the number of islets isolated from mouse pancreas. Islets 1, 185\u2013190 (2009).","journal-title":"Islets"},{"key":"BFnm3822_CR64","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0006-2952(98)00346-3","volume":"57","author":"D Janjic","year":"1999","unstructured":"Janjic, D. et al. Free radical modulation of insulin release in INS-1 cells exposed to alloxan. Biochem. Pharmacol. 57, 639\u2013648 (1999).","journal-title":"Biochem. Pharmacol."},{"key":"BFnm3822_CR65","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1523\/JNEUROSCI.3918-05.2006","volume":"26","author":"CD Kopec","year":"2006","unstructured":"Kopec, C.D., Li, B., Wei, W., Boehm, J. & Malinow, R. Glutamate receptor exocytosis and spine enlargement during chemically induced long-term potentiation. J. Neurosci. 26, 2000\u20132009 (2006).","journal-title":"J. Neurosci."},{"key":"BFnm3822_CR66","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/81649","volume":"26","author":"JP Silva","year":"2000","unstructured":"Silva, J.P. et al. Impaired insulin secretion and beta-cell loss in tissue-specific knockout mice with mitochondrial diabetes. Nat. Genet. 26, 336\u2013340 (2000).","journal-title":"Nat. Genet."},{"key":"BFnm3822_CR67","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676\u2013682 (2012).","journal-title":"Nat. Methods"},{"key":"BFnm3822_CR68","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cell.2004.09.033","volume":"119","author":"PO Berggren","year":"2004","unstructured":"Berggren, P.O. et al. Removal of Ca2+ channel beta3 subunit enhances Ca2+ oscillation frequency and insulin exocytosis. Cell 119, 273\u2013284 (2004).","journal-title":"Cell"},{"key":"BFnm3822_CR69","doi-asserted-by":"crossref","first-page":"e54638","DOI":"10.1371\/journal.pone.0054638","volume":"8","author":"A Sto\u017eer","year":"2013","unstructured":"Sto\u017eer, A., Dolensek, J. & Rupnik, M.S. Glucose-stimulated calcium dynamics in islets of Langerhans in acute mouse pancreas tissue slices. PLoS ONE 8, e54638 (2013).","journal-title":"PLoS ONE"},{"key":"BFnm3822_CR70","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jpba.2010.08.033","volume":"54","author":"WJ Loos","year":"2011","unstructured":"Loos, W.J. et al. Simultaneous quantification of dextromethorphan and its metabolites dextrorphan, 3-methoxymorphinan and 3-hydroxymorphinan in human plasma by ultra performance liquid chromatography\/tandem triple-quadrupole mass spectrometry. J. Pharm. Biomed. Anal. 54, 387\u2013394 (2011).","journal-title":"J. Pharm. Biomed. Anal."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm.3822.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.3822","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.3822.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T22:49:42Z","timestamp":1684450182000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm.3822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,16]]},"references-count":70,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["BFnm3822"],"URL":"https:\/\/doi.org\/10.1038\/nm.3822","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,16]]},"assertion":[{"value":"29 October 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.M., T.M. and E.L. pursue a patent application (WO 2013\/029762 A1) entitled Morphinan-derivatives for treating diabetes and related disorders.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}